Alan G. Fraser

3.5k total citations
69 papers, 2.7k citations indexed

About

Alan G. Fraser is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, Alan G. Fraser has authored 69 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 25 papers in Genetics and 16 papers in Immunology. Recurrent topics in Alan G. Fraser's work include Helicobacter pylori-related gastroenterology studies (25 papers), Inflammatory Bowel Disease (24 papers) and Gastroesophageal reflux and treatments (11 papers). Alan G. Fraser is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (25 papers), Inflammatory Bowel Disease (24 papers) and Gastroesophageal reflux and treatments (11 papers). Alan G. Fraser collaborates with scholars based in New Zealand, United Kingdom and Netherlands. Alan G. Fraser's co-authors include Lynnette R. Ferguson, R E Pounder, Dug Yeo Han, J Bickley, Angharad R. Morgan, D P Jewell, Elizabeth M. Robinson, Timothy R. Orchard, R.J. Owen and Euphemia Leung and has published in prestigious journals such as Gastroenterology, Gut and Journal of Clinical Microbiology.

In The Last Decade

Alan G. Fraser

68 papers receiving 2.6k citations

Peers

Alan G. Fraser
Kang‐Moon Lee South Korea
Klaus Ewe Germany
Jason K. Hou United States
Jimmy K. Limdi United Kingdom
Parakkal Deepak United States
Alan G. Fraser
Citations per year, relative to Alan G. Fraser Alan G. Fraser (= 1×) peers Bernard Duclos

Countries citing papers authored by Alan G. Fraser

Since Specialization
Citations

This map shows the geographic impact of Alan G. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Fraser more than expected).

Fields of papers citing papers by Alan G. Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Fraser. The network helps show where Alan G. Fraser may publish in the future.

Co-authorship network of co-authors of Alan G. Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Fraser. A scholar is included among the top collaborators of Alan G. Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Fraser. Alan G. Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krissansen, Geoffrey W., Yi Yang, Fiona McQueen, et al.. (2015). Overexpression of miR-595 and miR-1246 in the Sera of Patients with Active Forms of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21(3). 520–530. 46 indexed citations
2.
Popescu, Bogdan A., Petros Nihoyannopoulos, Simon Ray, et al.. (2014). Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging: an executive summary. European Heart Journal - Cardiovascular Imaging. 15(11). 1188–1193. 9 indexed citations
3.
Rjh, Smith, et al.. (2012). PMO-207 Changing trends in upper and lower gastrointestinal bleeding over a 13-years period. Gut. 61(Suppl 2). A158.1–A158. 1 indexed citations
4.
Morgan, Angharad R., et al.. (2012). Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population. Human Immunology. 73(4). 416–420. 33 indexed citations
5.
Morgan, Angharad R., Christopher M. Triggs, Alan G. Fraser, et al.. (2011). Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis. Human Immunology. 72(11). 1117–1127. 19 indexed citations
6.
Ferguson, Lynnette R., Dug Yeo Han, Alan G. Fraser, et al.. (2010). Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 690(1-2). 108–115. 101 indexed citations
7.
Triggs, Christopher M., Rong Hu, Alan G. Fraser, et al.. (2010). Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 690(1-2). 123–138. 73 indexed citations
8.
Morgan, Angharad R., et al.. (2010). PTPN2but notPTPN22is associated with Crohn's disease in a New Zealand population. Tissue Antigens. 76(2). 119–25. 14 indexed citations
9.
Han, Dug Yeo, et al.. (2009). Environmental factors in the development of chronic inflammation: A case–control study on risk factors for Crohn's disease within New Zealand. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 690(1-2). 116–122. 67 indexed citations
10.
Fraser, Alan G., Dion Morton, Dermot McGovern, Simon Travis, & D P Jewell. (2002). The efficacy of methotrexate for maintaining remission in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 16(4). 693–697. 90 indexed citations
11.
Bhat, Niranjan, James Gaensbauer, Alan G. Fraser, et al.. (1997). Country-specific constancy by age incagA+ proportion ofHelicobacter pylori infections. International Journal of Cancer. 72(3). 453–456. 89 indexed citations
12.
Fraser, Alan G.. (1997). Pharmacokinetic Interactions Between Alcohol and Other Drugs. Clinical Pharmacokinetics. 33(2). 79–90. 73 indexed citations
13.
Fraser, Alan G.. (1994). Review article: gastro‐oesophageal reflux and laryngeal symptoms. Alimentary Pharmacology & Therapeutics. 8(3). 265–272. 49 indexed citations
14.
Fraser, Alan G., et al.. (1994). Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Alimentary Pharmacology & Therapeutics. 8(2). 167–173. 80 indexed citations
15.
Fraser, Alan G., J. Sercombe, A. M. Sawyerr, et al.. (1993). Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.. Gut. 34(3). 338–342. 7 indexed citations
16.
Bickley, J, R.J. Owen, Alan G. Fraser, & R E Pounder. (1993). Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. Journal of Medical Microbiology. 39(5). 338–344. 136 indexed citations
17.
Prewett, Emily, et al.. (1992). Comparison of one‐day oral dosing with three bismuth compounds for the suppression of Helicobacter pylori assessed by the13C‐urea breath test. Alimentary Pharmacology & Therapeutics. 6(1). 97–102. 10 indexed citations
18.
Fraser, Alan G., Emily Prewett, R E Pounder, & I. Michael Samloff. (1992). Short report: twenty‐four‐hour hyperpepsinogenaemia in Helicobacter pylori‐positive subjects is abolished by eradication of the infection. Alimentary Pharmacology & Therapeutics. 6(3). 389–394. 22 indexed citations
19.
Fraser, Alan G., Mark Hudson, A. M. Sawyerr, S B Rosalki, & R E Pounder. (1992). Short report: the effect of ranitidine on the post‐prandial absorption of a low dose of alcohol. Alimentary Pharmacology & Therapeutics. 6(2). 267–271. 28 indexed citations
20.
Fraser, Alan G., Emily Prewett, Mark Hudson, et al.. (1991). The effect of ranitidine, cimetidine or famotidine on low‐dose post‐prandial alcohol absorption. Alimentary Pharmacology & Therapeutics. 5(3). 263–272. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026